Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Artificial sweeteners--do they bear a carcinogenic risk?

M R Weihrauch1, V Diehl

  • 1Department of Internal Medicine I of the University of Cologne, Cologne, Germany. martin.weihrauch@uni-koeln.de

Annals of Oncology : Official Journal of the European Society for Medical Oncology
|September 16, 2004
PubMed
Summary

This review examines whether common sugar substitutes increase cancer risk. By analyzing existing human and animal studies, the authors conclude that current evidence does not support a significant link between these additives and cancer development in the general population.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy.

British journal of cancer·2010
Same author

Nail dystrophy due to dose-intensive chemotherapy.

International journal of hematology·2009
Same author

CD40-activated B cells can be generated in high number and purity in cancer patients: analysis of immunogenicity and homing potential.

Clinical and experimental immunology·2008
Same author

[Hodgkin's lymphoma in nuclear medicine: diagnostic and therapeutic aspects].

Nuklearmedizin. Nuclear medicine·2003
Same author

Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease.

Annals of hematology·2002
Same author

Retrobulbar, intracranial, and cutaneous secondary plasmacytomas in a patient with atypical multiple myeloma.

The New England journal of medicine·2002

Area of Science:

  • Epidemiology and public health research within artificial sweeteners safety assessments
  • Oncology and toxicology studies regarding food additive safety

Background:

Public concern regarding the safety of sugar substitutes remains high despite widespread consumption. Media reports often highlight potential health hazards, causing significant confusion among consumers. No prior work had resolved whether these additives pose a genuine threat to human health. That uncertainty drove researchers to investigate the link between these substances and malignancy. It was already known that animal models occasionally yielded conflicting results compared to human data. This gap motivated a comprehensive assessment of available scientific literature. Prior research has shown that these compounds appear in numerous everyday products, from beverages to medications. The potential for population-wide exposure necessitates a clear understanding of their long-term safety profile.

Purpose Of The Study:

The aim of this study was to evaluate the potential carcinogenic risk associated with the consumption of sugar substitutes. Researchers sought to address the confusion caused by media reports regarding the safety of these additives. The investigation specifically targeted the validity of claims linking these substances to cancer development. By synthesizing existing literature, the authors intended to provide a clear overview for the public. The study addresses the necessity of distinguishing between animal-based findings and human epidemiological data. This work clarifies whether widespread exposure to these compounds poses a genuine health threat. The motivation stemmed from the ubiquity of these ingredients in modern diets across Western nations. The authors aimed to determine if current scientific evidence justifies the ongoing concerns regarding these common food components.

Keywords:
food safetysugar substitutesepidemiologycancer prevention

Frequently Asked Questions

The researchers propose that the overall risk of malignancy from these additives is negligible. While some studies observed an elevated relative risk of 1.3 for heavy consumers, this does not confirm a direct carcinogenic effect.

The authors evaluated first-generation compounds like saccharin, cyclamate, and aspartame, alongside newer options including acesulfame-K, sucralose, alitame, and neotame. These substances are frequently integrated into various consumer goods.

The authors state that animal models, specifically rats, previously indicated bladder cancer risks for saccharin and cyclamate. However, human epidemiological data failed to replicate these findings, demonstrating a discrepancy between species.

The team utilized PubMed searches to identify relevant English-language articles. This approach allowed for a broad synthesis of existing epidemiological and toxicological data.

Related Experiment Videos

Main Methods:

The review approach involved systematic searches of the National Library of Medicine database. Investigators focused on English-language publications to ensure comprehensive coverage. The team categorized compounds into first-generation and newer varieties for structured analysis. They examined both epidemiological human trials and historical animal experiments. This methodology allowed for a comparative assessment of diverse data sources. Researchers scrutinized case-control studies to identify potential correlations with malignancy. They evaluated consumption thresholds to determine if high intake levels influenced health outcomes. The design prioritized evidence-based synthesis to address public safety concerns regarding these common additives.

Main Results:

Key findings from the literature indicate that human epidemiological evidence does not support a link between these additives and cancer. Studies on saccharin and cyclamate failed to confirm the bladder malignancy risks previously observed in rodents. The authors report that no credible evidence suggests aspartame causes cancer in humans. Data revealed an elevated relative risk of 1.3 for individuals consuming over 1.7 grams of these substances daily. For newer generation compounds, the researchers state that insufficient epidemiological data exist to establish any risk. The analysis highlights that current product formulations often combine multiple sweeteners, complicating individual risk assessment. Overall, the literature suggests the potential for these substances to induce cancer is negligible. These results contrast with earlier, less rigorous assumptions regarding the safety of these common food ingredients.

Conclusions:

The authors suggest that the overall risk of cancer from these substances appears minimal. Synthesis and implications indicate that human data do not replicate findings observed in rodent models. Researchers propose that current evidence fails to support a causal link between these additives and malignancy. The review highlights that assessing individual compounds remains challenging due to product formulations containing multiple ingredients. Future efforts must account for the complexity of modern dietary patterns. The authors note that reports of elevated risk in heavy users require careful interpretation. This synthesis clarifies that existing data do not justify alarm regarding these common food components. The findings provide a balanced perspective on the safety of these widely used additives.

The authors measured carcinogenic risk by reviewing case-control studies and epidemiological reports. They specifically noted an elevated relative risk of 1.3 for individuals consuming over 1.7 grams of these substances daily.

The researchers propose that determining the danger of a single substance is difficult because modern products often combine multiple sweeteners. This complexity complicates the isolation of specific health effects.